Magnesium in PDB 8x22: Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Dgtp Ternary Complex
Protein crystallography data
The structure of Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Dgtp Ternary Complex, PDB code: 8x22
was solved by
Y.Yasutake,
S.I.Hattori,
H.Mitsuya,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
48.81 /
2.31
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
285.227,
285.227,
96.075,
90,
90,
120
|
R / Rfree (%)
|
18.3 /
21.9
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Dgtp Ternary Complex
(pdb code 8x22). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the
Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Dgtp Ternary Complex, PDB code: 8x22:
Jump to Magnesium binding site number:
1;
2;
Magnesium binding site 1 out
of 2 in 8x22
Go back to
Magnesium Binding Sites List in 8x22
Magnesium binding site 1 out
of 2 in the Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Dgtp Ternary Complex
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Dgtp Ternary Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg602
b:51.0
occ:1.00
|
O
|
A:VAL111
|
2.0
|
66.9
|
1.0
|
O1B
|
A:DGT601
|
2.0
|
52.4
|
1.0
|
O2G
|
A:DGT601
|
2.2
|
59.0
|
1.0
|
OD2
|
A:ASP185
|
2.2
|
54.1
|
1.0
|
O1A
|
A:DGT601
|
2.3
|
60.4
|
1.0
|
OD1
|
A:ASP110
|
2.4
|
61.9
|
1.0
|
PB
|
A:DGT601
|
3.2
|
57.4
|
1.0
|
C
|
A:VAL111
|
3.3
|
57.1
|
1.0
|
CG
|
A:ASP185
|
3.4
|
50.6
|
1.0
|
PG
|
A:DGT601
|
3.4
|
62.4
|
1.0
|
CG
|
A:ASP110
|
3.4
|
62.1
|
1.0
|
PA
|
A:DGT601
|
3.5
|
58.2
|
1.0
|
O3A
|
A:DGT601
|
3.7
|
58.8
|
1.0
|
O3B
|
A:DGT601
|
3.7
|
64.2
|
1.0
|
OD1
|
A:ASP185
|
3.9
|
52.7
|
1.0
|
OD2
|
A:ASP110
|
4.0
|
60.6
|
1.0
|
O1G
|
A:DGT601
|
4.0
|
60.1
|
1.0
|
C5'
|
A:DGT601
|
4.0
|
54.5
|
1.0
|
NZ
|
A:LYS220
|
4.1
|
78.5
|
1.0
|
N
|
A:VAL111
|
4.1
|
52.0
|
1.0
|
CA
|
A:GLY112
|
4.1
|
52.6
|
1.0
|
N
|
A:GLY112
|
4.1
|
54.2
|
1.0
|
CA
|
A:VAL111
|
4.2
|
53.3
|
1.0
|
O5'
|
A:DGT601
|
4.3
|
58.3
|
1.0
|
N
|
A:ASP113
|
4.3
|
50.2
|
1.0
|
O2B
|
A:DGT601
|
4.5
|
61.2
|
1.0
|
C
|
A:GLY112
|
4.5
|
54.6
|
1.0
|
O3G
|
A:DGT601
|
4.5
|
67.8
|
1.0
|
CB
|
A:ASP185
|
4.5
|
45.9
|
1.0
|
C
|
A:ASP110
|
4.6
|
53.1
|
1.0
|
CB
|
A:ASP110
|
4.6
|
57.5
|
1.0
|
CB
|
A:ALA114
|
4.6
|
34.0
|
1.0
|
O2A
|
A:DGT601
|
4.6
|
64.9
|
1.0
|
N
|
A:ALA114
|
4.7
|
46.7
|
1.0
|
CE
|
A:LYS220
|
4.7
|
79.0
|
1.0
|
CB
|
A:VAL111
|
4.9
|
50.5
|
1.0
|
|
Magnesium binding site 2 out
of 2 in 8x22
Go back to
Magnesium Binding Sites List in 8x22
Magnesium binding site 2 out
of 2 in the Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Dgtp Ternary Complex
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Dgtp Ternary Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg602
b:55.7
occ:1.00
|
O
|
C:VAL111
|
2.0
|
83.3
|
1.0
|
O1B
|
C:DGT601
|
2.1
|
59.5
|
1.0
|
OD2
|
C:ASP185
|
2.2
|
77.0
|
1.0
|
OD2
|
C:ASP110
|
2.4
|
71.5
|
1.0
|
O1G
|
C:DGT601
|
2.5
|
79.3
|
1.0
|
O1A
|
C:DGT601
|
2.6
|
59.6
|
1.0
|
C
|
C:VAL111
|
3.2
|
70.1
|
1.0
|
PB
|
C:DGT601
|
3.3
|
70.5
|
1.0
|
CG
|
C:ASP185
|
3.4
|
67.0
|
1.0
|
PG
|
C:DGT601
|
3.5
|
80.9
|
1.0
|
CG
|
C:ASP110
|
3.6
|
68.9
|
1.0
|
O3B
|
C:DGT601
|
3.8
|
75.3
|
1.0
|
PA
|
C:DGT601
|
3.8
|
68.2
|
1.0
|
OD1
|
C:ASP185
|
3.9
|
65.6
|
1.0
|
O3A
|
C:DGT601
|
3.9
|
75.3
|
1.0
|
CA
|
C:GLY112
|
3.9
|
64.9
|
1.0
|
N
|
C:GLY112
|
4.0
|
67.3
|
1.0
|
O3G
|
C:DGT601
|
4.0
|
83.0
|
1.0
|
N
|
C:ASP113
|
4.1
|
65.7
|
1.0
|
N
|
C:VAL111
|
4.1
|
62.9
|
1.0
|
CA
|
C:VAL111
|
4.2
|
64.9
|
1.0
|
C5'
|
C:DGT601
|
4.2
|
62.0
|
1.0
|
NZ
|
C:LYS220
|
4.3
|
81.6
|
1.0
|
OD1
|
C:ASP110
|
4.3
|
67.4
|
1.0
|
C
|
C:GLY112
|
4.3
|
64.2
|
1.0
|
CD
|
C:LYS220
|
4.3
|
81.5
|
1.0
|
C
|
C:ASP110
|
4.5
|
62.1
|
1.0
|
N
|
C:ALA114
|
4.5
|
57.8
|
1.0
|
CB
|
C:ASP185
|
4.5
|
58.3
|
1.0
|
O2B
|
C:DGT601
|
4.5
|
68.2
|
1.0
|
CB
|
C:ASP110
|
4.6
|
63.2
|
1.0
|
O5'
|
C:DGT601
|
4.6
|
64.6
|
1.0
|
CB
|
C:ALA114
|
4.6
|
49.6
|
1.0
|
CE
|
C:LYS220
|
4.8
|
82.7
|
1.0
|
O2G
|
C:DGT601
|
4.8
|
84.9
|
1.0
|
CB
|
C:VAL111
|
4.8
|
61.0
|
1.0
|
O
|
C:ASP110
|
4.9
|
62.2
|
1.0
|
O2A
|
C:DGT601
|
5.0
|
73.4
|
1.0
|
|
Reference:
Y.Yasutake,
S.I.Hattori,
H.Kumamoto,
N.Tamura,
K.Maeda,
H.Mitsuya.
Deviated Binding of Anti-Hbv Nucleoside Analog E-Cfcp-Tp to the Reverse Transcriptase Active Site Attenuates the Effect of Drug-Resistant Mutations. Sci Rep V. 14 15742 2024.
ISSN: ESSN 2045-2322
PubMed: 38977798
DOI: 10.1038/S41598-024-66505-Z
Page generated: Sat Oct 5 00:58:29 2024
|